Ricky R. Zhang
Lika, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Broad-spectrum humanized monoclonal neutralizing antibody against SARS-CoV-2 variants, including the Omicron variant.
Journal: Frontiers in cellular and infection microbiology
Published: April 28, 2023
Serum neutralisation of the SARS-CoV-2 omicron sublineage BA.2.
Journal: The Lancet. Microbe
Published: April 04, 2022
Boosting of serum neutralizing activity against the Omicron variant among recovered COVID-19 patients by BNT162b2 and CoronaVac vaccines.
Journal: EBioMedicine
Published: February 07, 2022
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 28, 2021
Correlation between Commercial Anti-RBD IgG Titer and Neutralization Titer against SARS-CoV-2 Beta Variant.
Journal: Diagnostics (Basel, Switzerland)
Published: October 06, 2021
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 04, 2021
Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Platform to Study SARS-CoV-2 Related Myocardial Injury.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: September 28, 2020
Factors affecting stability and infectivity of SARS-CoV-2.
Journal: The Journal of hospital infection
Published: April 21, 2020
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Journal: Lancet (London, England)
Published: April 03, 2020
SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series.
Journal: The Lancet. Infectious diseases
Published: March 20, 2020
Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.
Journal: Gastroenterology
Published: March 16, 2020
Last Updated: 09/26/2026